Early Sclerostin Expression Explains Bone Formation Inhibition Before Arthritis Onset in the Rat Adjuvant-induced Arthritis Model

Overview

Journal Sci Rep

Specialty Science

Date 2018 Feb 24

PMID 29472591

Citations 13

Authors

Guillaume Courbon

Raphaelle Lamarque

Maude Gerbaix

Robin Caire

Marie-Therese Linossier

Norbert Laroche

Mireille Thomas

Thierry Thomas

Laurence Vico

Hubert Marotte

Affiliations

Soon will be listed here.

Abstract

Periarticular bone loss in rheumatoid arthritis (RA) is considered to be mainly related to synovial inflammation. However, strong bone loss has also described at the time of arthritis onset. Recently, a paradoxical exacerbation of joint damage was described when blocking sclerostin in various arthritis models. Thus, we aimed to determine kinetics of bone loss and its mechanisms in the adjuvant induced arthritis (AIA) rat model of RA. AIA was induced (n = 35) or not (n = 35) at day 0. In addition to well-known arthritis at day 12, we showed with 3D-imaging and histomorphometry that bone microstructural alterations occurred early from day 8 post-induction, characterized by cortical porosity and trabecular bone loss. Active osteoclastic surfaces were increased from day 8 with RANKL upregulation. More surprisingly SOST and DKK1 were overexpressed from day 6 and followed by a dramatic decrease in bone formation from day 8. At the time of arthritis onset, SOST and DKK1 returned to control values, but frizzled related protein 1 (SFRP1), proinflammatory cytokines, and MMPs started to increase. Bone alterations before arthritis onset reinforce the hypothesis of an early bone involvement in arthritis. Kinetics of osteocyte markers expression should be considered to refine Wnt inhibitor treatment strategies.

Citing Articles

Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated Review.

Orsini F, Crotti C, Cincinelli G, Di Taranto R, Amati A, Ferrito M Biology (Basel). 2023; 12(10).

PMID: 37887030 PMC: 10604370. DOI: 10.3390/biology12101320.

Host and bacterial factors linking periodontitis and rheumatoid arthritis.

Krutyholowa A, Strzelec K, Dziedzic A, Bereta G, Lazarz-Bartyzel K, Potempa J Front Immunol. 2022; 13:980805.

PMID: 36091038 PMC: 9453162. DOI: 10.3389/fimmu.2022.980805.

Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions.

Komatsu N, Takayanagi H Nat Rev Rheumatol. 2022; 18(7):415-429.

PMID: 35705856 DOI: 10.1038/s41584-022-00793-5.

Positive and Negative Regulators of Sclerostin Expression.

Iwamoto R, Koide M, Udagawa N, Kobayashi Y Int J Mol Sci. 2022; 23(9).

PMID: 35563281 PMC: 9102037. DOI: 10.3390/ijms23094895.

Improvement of Pain Management by Nefopam in a Rat Adjuvant-Induced Arthritis Model.

Dalix E, Maalouf M, Linossier M, Vanden-Bossche A, Peyroche S, Marotte H Front Vet Sci. 2022; 9:809980.

PMID: 35558888 PMC: 9087999. DOI: 10.3389/fvets.2022.809980.

References

Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham 3rd C . 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010; 69(9):1580-8. DOI: 10.1136/ard.2010.138461. View

Chan B, Fuller E, Russell A, Smith S, Smith M, Jackson M . Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage. 2011; 19(7):874-85. DOI: 10.1016/j.joca.2011.04.014. View

Okamoto M, Udagawa N, Uehara S, Maeda K, Yamashita T, Nakamichi Y . Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis. Sci Rep. 2014; 4:4493. PMC: 3967152. DOI: 10.1038/srep04493. View

Ljusberg J, Wang Y, Lang P, Norgard M, Dodds R, Hultenby K . Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J Biol Chem. 2005; 280(31):28370-81. DOI: 10.1074/jbc.M502469200. View

Schett G, Firestein G . Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis. 2010; 69(5):787-9. DOI: 10.1136/ard.2009.121657. View

Chen X, Baum W, Dwyer D, Stock M, Schwabe K, Ke H . Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis. Ann Rheum Dis. 2013; 72(10):1732-6. PMC: 3786639. DOI: 10.1136/annrheumdis-2013-203345. View

Hill P, Murphy G, Docherty A, Hembry R, Millican T, Reynolds J . The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci. 1994; 107 ( Pt 11):3055-64. DOI: 10.1242/jcs.107.11.3055. View

Kleyer A, Krieter M, Oliveira I, Faustini F, Simon D, Kaemmerer N . High prevalence of tenosynovial inflammation before onset of rheumatoid arthritis and its link to progression to RA-A combined MRI/CT study. Semin Arthritis Rheum. 2016; 46(2):143-150. DOI: 10.1016/j.semarthrit.2016.05.002. View

Iwata T, Ito H, Furu M, Hashimoto M, Fujii T, Ishikawa M . Periarticular osteoporosis of the forearm correlated with joint destruction and functional impairment in patients with rheumatoid arthritis. Osteoporos Int. 2015; 27(2):691-701. DOI: 10.1007/s00198-015-3256-1. View

10.

Schett G, Stolina M, Bolon B, Middleton S, Adlam M, Brown H . Analysis of the kinetics of osteoclastogenesis in arthritic rats. Arthritis Rheum. 2005; 52(10):3192-201. DOI: 10.1002/art.21343. View

11.

Seror R, Boudaoud S, Pavy S, Nocturne G, Schaeverbeke T, Saraux A . Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort. Sci Rep. 2016; 6:18421. PMC: 4726234. DOI: 10.1038/srep18421. View

12.

Krishnan V, Bryant H, MacDougald O . Regulation of bone mass by Wnt signaling. J Clin Invest. 2006; 116(5):1202-9. PMC: 1451219. DOI: 10.1172/JCI28551. View

13.

Paccou J, Mentaverri R, Renard C, Liabeuf S, Fardellone P, Massy Z . The relationships between serum sclerostin, bone mineral density, and vascular calcification in rheumatoid arthritis. J Clin Endocrinol Metab. 2014; 99(12):4740-8. DOI: 10.1210/jc.2014-2327. View

14.

Huang J, Sakata T, Pfleger L, Bencsik M, Halloran B, Bikle D . PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res. 2004; 19(2):235-44. DOI: 10.1359/JBMR.0301226. View

15.

Yeremenko N, Zwerina K, Rigter G, Pots D, Fonseca J, Zwerina J . Tumor necrosis factor and interleukin-6 differentially regulate Dkk-1 in the inflamed arthritic joint. Arthritis Rheumatol. 2015; 67(8):2071-5. DOI: 10.1002/art.39183. View

16.

Rossini M, Viapiana O, Adami S, Fracassi E, Idolazzi L, Dartizio C . In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density. Clin Exp Rheumatol. 2014; 33(1):77-83. View

17.

Piemontese M, Xiong J, Fujiwara Y, Thostenson J, OBrien C . Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. Am J Physiol Endocrinol Metab. 2016; 311(3):E587-93. PMC: 5142003. DOI: 10.1152/ajpendo.00219.2016. View

18.

Wehmeyer C, Frank S, Beckmann D, Bottcher M, Cromme C, Konig U . Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction. Sci Transl Med. 2016; 8(330):330ra35. DOI: 10.1126/scitranslmed.aac4351. View

19.

Benedetti G, Miossec P . Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. Eur J Immunol. 2013; 44(2):339-47. DOI: 10.1002/eji.201344184. View

20.

Fardellone P, Sejourne A, Paccou J, Goeb V . Bone remodelling markers in rheumatoid arthritis. Mediators Inflamm. 2014; 2014:484280. PMC: 4009257. DOI: 10.1155/2014/484280. View